Eisai Plans Sales Force Of 100 To Market Cancer Drugs In Europe
This article was originally published in PharmAsia News
Executive Summary
Eisai plans to establish a sales force for its anti-cancer drugs in Europe, where it expects to launch one product to treat breast cancer this fiscal year